CompletedNot Applicable

Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery

Denmark40 participantsStarted 2015-10

Plain-language summary

The purpose of this randomized study is to examine the effect of a selective suprascapular nerve block on post operative pain after arthroscopic shoulder surgery. Half of the subjects will receive a active nerve block with Ropivacain. Half of the subjects will receive a placebo nerve block with saline.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients planned for arthroscopic shoulder surgery. * Age ≥ 18. * ASA class ≤ 3. Exclusion Criteria: * Patients with VAS never ≥5 mm during the first hour after arrivel to the post anesthesia care unit. * Patients unable to cooperate. * Patients unable to understand or speak danish. * Allergy towards the used drugs. * Abuse of alcohol- and/or medicine - investigators assessment. * Usage of opioids on a daily basis (not including Tramadole). * Pregnancy (It is obligatory for all fertile women in the study to take a hcg urine test). * Operations involving the clavicle. * Operations converted to open surgery.

What they're measuring

Visual analogue scale (VAS) score at rest at T½

Timeframe: Baseline to 30 minutes

Trial details

NCT IDNCT02576223

SponsorKai Henrik Wiborg Lange

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-08-27

View on ClinicalTrials.gov More Pain trials